Soaring to save lives Soaring to save lives Tackling health disparities through drone delivery of vaccines animals and livestock living in underserved communities
All hands-on deck to fight the ‘zombie’ rabies virus All hands-on deck to fight the ‘zombie’ rabies virus We’re teaming up with communities and governments across Southeast Asia to fight rabies through vaccinations, education programs, and partnerships.
U.S. FDA grants priority review for spesolimab in GPP U.S. FDA grants priority review for spesolimab in GPP U.S. FDA grants priority review for spesolimab in the treatment of patients with generalized pustular psoriasis
Siva Thotapalli Siva Thotapalli My career challenge at Boehringer Ingelheim by Siva Thotapalli. Read it now!
Boehringer expands cancer research at Vienna site Boehringer expands cancer research at Vienna site Boehringer Ingelheim expands cancer research at its Vienna site
Spesolimab prevents GPP flares Spesolimab prevents GPP flares Spesolimab prevents generalized pustular psoriasis flares in EFFISAYIL™ 2 trial
Nerandomilast primary endpoint phase-3 FIBRONEER-IPF met Nerandomilast primary endpoint phase-3 FIBRONEER-IPF met Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study
Growing with us Growing with us We recognize the benefits of learning and have created an environment where life-long learning and personal growth are encouraged for all employees.
Generalized pustular psoriasis: Value of community support Generalized pustular psoriasis: Value of community support Dr Clerisme-Beaty and Dr Strober MD, PhD discuss the importance of knowledge sharing, community support and challenges faced by those living with GPP.
New study paves the way for liver cirrhosis treatments New study paves the way for liver cirrhosis treatments The ADVANCE study will be the most detailed observational study of its kind providing a detailed analysis of liver health.
BI_PharmAccess_launch_digital_healthcare_program BI_PharmAccess_launch_digital_healthcare_program Boehringer Ingelheim and PharmAccess launch a new mobile support program „Tiba Yako“ to empower patients to become more aware, access care and take charge of their disease management
Zongertinib positive results non-small cell lung cancer Zongertinib positive results non-small cell lung cancer Boehringer’s zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients
Women in STEM 2022 Women in STEM 2022 Meet three of Boehringer Ingelheim's female scientists and learn why and how women are making a difference in STEM.
Smart Factory: Digitalizing production facilities Smart Factory: Digitalizing production facilities How our digitalized production facilities help our colleagues and patients
Supporting grooms in equestrian sports Supporting grooms in equestrian sports Find out how one organization can change the lives of those who dedicate their careers to horse care.
Small Cell Lung Cancer Small Cell Lung Cancer Discover more about small cell lung cancer, including its symptoms and treatment options.
A life in a day: the reality of living with lung cancer A life in a day: the reality of living with lung cancer Within the initiative “A life in a day”, Anna-Maria spent 24 hours in the shoes of a lung cancer patient to better understand the patient experience.
Discover your hidden talent with BI Open – the new platform for data science enthusiasts Discover your hidden talent with BI Open – the new platform for data science enthusiasts Discover your hidden talent with BI Open – the new platform for data science enthusiasts. For more talent insights, visit our Careers Page.
The impact of carbon reduction projects The impact of carbon reduction projects Boehringer Ingelheim voluntarily contributes to carbon reduction projects that benefit sustainable development.
Boehringer Ingelheim collaborates with Circle Pharma Boehringer Ingelheim collaborates with Circle Pharma Boehringer Ingelheim collaborates with Circle Pharma to develop a first-in-class cyclin RxL inhibitor that can halt the growth of cancer cells
Covid Global Support Programm Covid Global Support Programm COVID-19: Boehringer Ingelheim steps up effort with Global Support Program
Our culture Our culture Our culture reflects who we are and is reflected in Our FOCUS and strong belief in Diversity, Equity and Inclusion as well as Sustainable Development.
Tips to help you start your patient advocacy journey Tips to help you start your patient advocacy journey Advocating for yourself as a patient can be daunting. Jeff Dunn, President of Union for International Cancer Control (UICC), shares some tips